Reference standard provider acquired
Sigma-Aldrich has acquired Cerilliant of Round Rock, Texas, USA, strengthening the company?s analytical chemistry product portfolio.
Sigma-Aldrich has acquired Cerilliant of Round Rock, Texas, USA, strengthening the company’s analytical chemistry product portfolio. Cerilliant supplies reference standards and materials to support the clinical diagnostics, environmental, nutraceutical, pharmaceutical, forensic and clinical toxicology markets.
“Cerilliant’s strong product suite and solid relationships with customers and analytical equipment suppliers will bring important new business opportunities to our company,” commented Russel Gant, vice president of the Analytical Research business at Sigma-Aldrich. He goes on to say that the combination of the companies “will provide analytical customers around the globe with access to a broad and ever-increasing range of specialized, high-quality analytical standards from a convenient and reliable single source.”
According to the companies, Cerilliant is experienced in the design, development, synthesis, characterization and packaging of analytical standards, calibrators, controls and certified reference materials and is accredited to ISO Guide 34, ISO/IEC 17025 and is certified to ISO 9001:2008. Its capabilities are expected to complement Sigma-Aldrich’s Fluka and Supelco analytical brands.
Sherri Pogue, president of Cerilliant added, “Being part of the Sigma-Aldrich family will provide Cerilliant with the depth and breadth of resources that will allow us to continue to expand our development and offering of innovative products to support our customers’ ever-evolving analytical requirements.”
This story originally appeared in The Column. Click here to view that issue.
Determining the Link Between Prenatal Cannabis Use and Symptoms of Depression Using LC–MS/MS
April 16th 2025Researchers investigating the relationship between cannabis use during pregnancy and depressive symptoms—and whether continued use beyond the first trimester or higher levels of use were linked to increased symptoms—used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to confirm the presence of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH) in urine samples.
A Guide to (U)HPLC Column Selection for Protein Analysis
April 16th 2025Analytical scientists are faced with the task of finding the right column from an almost unmanageable range of products. This paper focuses on columns that enable protein analysis under native conditions through size exclusion, hydrophobic interaction, and ion exchange chromatography. It will highlight the different column characteristics—pore size, particle size, base matrices, column dimensions, ligands—and which questions will help decide which columns to use.
Common Challenges in Nitrosamine Analysis: An LCGC International Peer Exchange
April 15th 2025A recent roundtable discussion featuring Aloka Srinivasan of Raaha, Mayank Bhanti of the United States Pharmacopeia (USP), and Amber Burch of Purisys discussed the challenges surrounding nitrosamine analysis in pharmaceuticals.
